Skip to content

Ultrasound Guided Percutaneous Tracheostomy Compared to Bronchoscopy Guided Percutaneous Tracheostomy

Ultrasound Guided Percutaneous Tracheostomy Compared to Bronchoscopy Guided Percutaneous Tracheostomy - A Randomized Non-inferiority Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02084862
Acronym
TRACHUS
Enrollment
118
Registered
2014-03-12
Start date
2014-03-31
Completion date
2015-06-30
Last updated
2015-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheostomy Complications

Keywords

Tracheostomy, Ultrasound

Brief summary

TRACHUS trial is a randomized non-inferiority trial designed to evaluate the safety and efficacy of ultrasound guided percutaneous tracheostomy compared to bronchoscopy guided percutaneous tracheostomy.

Detailed description

TRACHUS trial is a randomized non-inferiority trial designed to evaluate the safety and efficacy of ultrasound guided percutaneous tracheostomy compared to bronchoscopy guided percutaneous tracheostomy. Patients will be randomly assigned to be submitted to ultrasound or bronchoscopy guided percutaneous tracheostomy and then the procedure related complications and clinical outcomes will be evaluated and compared between groups.

Interventions

Ultrasound guided percutaneous tracheostomy

Bronchoscopy guided percutaneous tracheostomy

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All intubated and mechanically ventilated patients indicated for a tracheostomy by the ICU assistant team

Exclusion criteria

* Patients with unfavorable anatomy judged by the patient assistant team (short neck, tracheal deviation, cervical anatomical anomaly, previous cervical surgery, cervical trauma or inability to perform neck extension), preference for surgical tracheostomy by the patient assistant team or patients unable to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Procedure failureDuring PDT - an expected average of 15 minutesCombined endpoint procedure failure (defined as conversion to surgical tracheostomy, or associated use of bronchoscopy in the case of ultrasound-guided tracheostomy or associated use of ultrasound in bronchoscopy-guided tracheostomy) or occurrence of of a major complications defined as transfusion, hypotension or surgical intervention in the operative room due to bleeding, tracheal laceration, tracheal posterior wall injury, esophageal injury, tracheoesophageal fistula, cardiorespiratory arrest or death due to tracheostomy.

Secondary

MeasureTime frameDescription
Length of Mechanical VentilationParticipants will be followed for the duration of hospital stay, an expected average of 4 weeksLength of Mechanical Ventilation
Length of Hospital StayParticipants will be followed for the duration of hospital stay, an expected average of 4 weeksLength of Hospital Stay
HypoxemiaDuring PDT - an expected average of 15 minutesDrop in peripheral oxygen saturation \< 90% for more than 2 minutes as measured by pulse oxymeter during the procedure
HypotensionDuring PDT - an expected average of 15 minutesSystolic blood pressure \< 90mmHg for more than 5 minutes and any intervention aimed to raise blood pressure such as vasopressor or fluid administration.
PneumothoraxParticipants will be followed for the duration of hospital stay, an expected average of 4 weeksPneumothorax due to the PDT detected by clinical examination during the procedure or chest x-ray after the procedure.
AtelectasisParticipants will be followed for the duration of hospital stay, an expected average of 4 weeksAtelectasis due to the PDT detected by clinical examination during the procedure or chest x-ray after the procedure.
Conversion to surgical tracheostomyDuring PDT - an expected average of 15 minutesConversion to surgical tracheostomy due to technical limitations or complications during PDT.
Tracheal posterior wall injuryParticipants will be followed for the duration of hospital stay, an expected average of 4 weeksTracheal posterior wall injury as detected by bronchoscopy after the procedure
Accidental decanulationParticipants will be followed for the duration of hospital stay, an expected average of 4 weeksAccidental decanulation after the procedure during Hospital stay
Minor bleedingParticipants will be followed for the duration of hospital stay, an expected average of 4 weeksClinical relevant bleeding attributed to PDT defined as need for any intervention to stop the bleeding such as vessel ligature or local wound care.
Major bleedingDuring the procedure - an expected average of 15 minutesBlood transfusion or hypotension or surgical intervention in the operating room due to bleeding during PDT
Cardiorespiratoty arrestDuring PDT - an expected average of 15 minutesCardiorespiratory arrest due to PDT
DeathParticipants will be followed for the duration of hospital stay, an expected average of 4 weeksDeath due to PDT complications
Liberation from mechanical ventilationParticipants will be followed for the duration of hospital stay, an expected average of 4 weeksBreathing without ventilator assistance for at least 48 hours after the PDT
Length of ICU StayParticipants will be followed for the duration of hospital stay, an expected average of 4 weeksLength of ICU Stay
Surgical site infectionParticipants will be followed for the duration of hospital stay, an expected average of 4 weeksSurgical site infection defined as antibiotic introduction directed to surgical site
Tracheal ring fractureParticipants will be followed for the duration of hospital stay, an expected average of 4 weeksTracheal ring fracture detected by bronchosocopy after the PDT
Tracheal-esophageal fistulaParticipants will be followed for the duration of hospital stay, an expected average of 4 weeksTrachealesophageal fistula detected by bronchosocopy after PDT

Other

MeasureTime frameDescription
Procedure durationDuring PDT - an expected average of 15 minutesTime elapsed between skin incision and connection of mechanical ventilation to tracheostomy cannula
Time to procedure performanceParticipants will be followed for the duration of hospital stay, an expected average of 4 weeksTime elapsed between participant randomization and PDT performance

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026